Most with OSA see improvement one year after bariatric surgery

Reuters Health Information: Most with OSA see improvement one year after bariatric surgery

Most with OSA see improvement one year after bariatric surgery

Last Updated: 2017-02-01

By Reuters Staff

NEW YORK (Reuters Health) - One year after bariatric surgery, most patients with obstructive sleep apnea (OSA) have major improvements in their symptoms, new research shows.

And OSA was cured in 45% of patients, Dr. Pipsa Peromaa-Haavisto of Hatanpaa City Hospital in Tampere, Finland, and colleagues report in Sleep Medicine online January 12.

The researchers looked at 187 patients who underwent laparoscopic Roux-en-Y gastric bypass (LRYGB) at three Finnish hospitals. At baseline, 132 (71%) had OSA, including 22% with severe symptoms, 18% with moderate OSA, and 31% with mild OSA.

Cardiorespiratory recordings at one year were available for 164 patients, 72 of whom had OSA; 45% of patients had no OSA symptoms, 7% had severe OSA, 13% had moderate OSA, and 35% had mild OSA. The average apnea-hypopnea index (AHA) had dropped from 27.8 events per hour to 9.9 events per hour (p<0.001).

While 90% of men had OSA at baseline, this had decreased to 52% one year later. Eight percent of the patients developed de novo OSA,

The researchers found no predictors for whether or not a patient's OSA would improve with surgery.

"Bariatric surgery is an effective treatment for OSA, but it is impossible to predict which patients will have persisting symptoms," Dr. Peromaa-Haavisto and colleagues write. "Postoperative cardiorespiratory recordings are needed in order to find the approximately 20% of patients who still have persistent moderate or severe OSA 12 months after surgery."

Dr. Peromaa-Haavisto was not available for an interview by press time.


Sleep Med 2017.

© Copyright 2013-2020 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.